Progress report on the first sub-Saharan Africa trial of newer versus older antihypertensive drugs in native black patients

Trials

Volumn 13, Issue , 2012, Pages

  Odili, Augustine N ^a,b   Ezeala Adikaibe, Birinus ^a,c   Ndiaye, Mouhamadou B ^e   Anisiuba, Benedict C ^c   Kamdem, Marius M ^d   Ijoma, Chinwuba K ^c   Kaptue, Joseph ^d   Boombhi, Hilaire J ^f   Kolo, Philip M ^g   Shu, Elvis N ^c   Thijs, Lutgarde ^a   Staessen, Jan A ^a,h   Omotoso, Babatunde A ^g   Kingue, Samuel ^f   Ba, Serigne A ^e   Lemogoum, Daniel ^d   M'Buyamba Kabangu, Jean René ⁱ   Ulasi, Ifeoma I ^c  

^a Studies Coordinating Centre   (Belgium)

^b UNIVERSITY OF ABUJA   (Nigeria)

^c UNIVERSITY OF NIGERIA   (Nigeria)

^d Douala Cardiovascular Research Institute   (Cameroon)

^e Centre Hospitalier Universitaire Dakar   (Senegal)

^f YAOUNDÉ GENERAL HOSPITAL   (Cameroon)

^g UNIVERSITY OF ILORIN   (Nigeria)

^h MAASTRICHT UNIVERSITY   (Netherlands)

ⁱ University of Kinshasa   (Democratic Republic Congo)

Author keywords

Antihypertensive therapy; Health policy and outcome research; Randomized clinical trial; Special populations

Indexed keywords

AMLODIPINE PLUS VALSARTAN; BISOPROLOL FUMARATE PLUS HYDROCHLOROTHIAZIDE; METHYLDOPA;

ADULT; AFRICA SOUTH OF THE SAHARA; AGED; ARTICLE; ASTHENIA; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIARRHEA; DRUG DOSE INCREASE; FATIGUE; FEMALE; FOLLOW UP; HEARTBURN; HOT FLUSH; HUMAN; HYPERTENSION; INDIGENOUS PEOPLE; INSOMNIA; LABORATORY TEST; LEG EDEMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

ADMINISTRATION, ORAL; ADULT; AFRICA SOUTH OF THE SAHARA; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BISOPROLOL; BLOOD PRESSURE; DIURETICS; DRUG COMBINATIONS; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED; PATIENT DROPOUTS; PATIENT SELECTION; RISK FACTORS; TABLETS; TETRAZOLES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84861083664     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-13-59     Document Type: Article

References (45)

1. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998, 97:596-601. 10.1161/01.CIR.97.6.596, 9494031.
2. Bonita R, Reddy S, Galbraith S, Bettcher D, MacIntyre M, Peden M, Rozenberg M, Vu C. Neglected global epidemics: three growing threats. The World Health Report 2003 - Shaping the Future 2003, 83-102. World Health Organization, Geneva, Switzerland, Beaglehole R, Irwin A, Prentice T.
3. Perkovic V, Huxley R, Wu Y, Prabhakaran PD, MacMahon S. The burden of blood pressure-related disease: a neglected priority in global health. Hypertension 2007, 50:991-997. 10.1161/HYPERTENSIONAHA.107.095497, 17954719.
4. Donnison C. Blood pressure in African natives: its bearing on the aetiology of hyperpiesa and arteriosclerosis. Lancet 1929, i:6-7.
5. Opie LH, Seedat YK. Hypertension in sub-Saharan African populations. Circulation 2005, 112:3562-3568. 10.1161/CIRCULATIONAHA.105.539569, 16330697.
6. Whitworth JA, , . World Health Organization ISoHWG, World Health Organization ISoHWG 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003, 21:1983-1992. World Health Organization ISoHWG, World Health Organization ISoHWG.
7. Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J, , . ASCOT Investigators, ASCOT Investigators Prevention of cardiovascular events with an amlodipine ± perindopril strategy compared with an atenolol ± thiazide strategy. The Anglo-Scandinavian Cardiac Outcomes Trial - Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005, 366:895-906. 10.1016/S0140-6736(05)67185-1, 16154016, ASCOT Investigators, ASCOT Investigators.
8. Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velaquez EJ, , . ACCOMPLISH Trial Investigators, ACCOMPLISH Trial Investigators Benazapril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008, 359:2417-2428. 10.1056/NEJMoa0806182, 19052124, ACCOMPLISH Trial Investigators, ACCOMPLISH Trial Investigators.
9. Odili AN, Richart T, Thijs L, Kingue S, Boombhi HJ, Lemogoum D, Kaptue J, Kamden M, Mipinda JB, Omotoso BA, Kolo PM, Aderibigbe A, Ulasi II, Anisiuba BC, Ijoma CK, Ba SA, Ndiaye MB, Staessen JA, M'buyamba-Kabangu JR, , . NOAAH Investigators, NOAAH Investigators Rationale and design of the Newer Versus Older Antihypertensive Agents In African Hypertensive Patients (NOAAH) trial. Blood Press 2011, 20:256-266. 10.3109/08037051.2011.572614, 21495829, NOAAH Investigators, NOAAH Investigators.
10. World Medical Assembly Declaration of Helsinki: recommendations guiding physicians in biomedical research involving human subjects. Bull Pan Am Health Organ 1990, 24:606-609. World Medical Assembly.
11. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, et al. Guidelines for the management of arterial hypertension. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105-1187. 10.1097/HJH.0b013e3281fc975a, 17563527.
12. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabet Care 1999, 22(suppl 1):S5-S19. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
13. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949, 37:161-186. 10.1016/0002-8703(49)90562-1, 18107386.
14. Casale PN, Devereux RB, Alonso DR, Campo E, Kligfield P. Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation 1987, 75:565-572. 10.1161/01.CIR.75.3.565, 2949887.
15. Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol 1995, 24:417-423.
16. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, et al. 2007 guidelines for the management of arterial hypertension. Eur Heart J 2007, 28:1462-1536.
17. El Assaad MA, Topouchian JA, Asmar RG. Evaluation of two devices for self-measurement of blood pressure according to the international protocol: the Omron M5-I and the Omron 705IT. Blood Press Monit 2003, 8:127-133. 10.1097/00126097-200306000-00006, 12900590.
18. O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P, , . European Society of Hypertension Working Group on Blood Pressure Monitoring, European Society of Hypertension Working Group on Blood Pressure Monitoring Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 2005, 23:697-701. 10.1097/01.hjh.0000163132.84890.c4, 15775768, European Society of Hypertension Working Group on Blood Pressure Monitoring, European Society of Hypertension Working Group on Blood Pressure Monitoring.
19. Staessen JA, Byttebier G, Buntinx F, Celis H, O'Brien ET, Fagard R. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators. JAMA 1997, 278:1065-1072. 10.1001/jama.1997.03550130039034, 9315764.
20. Staessen JA, Den Hond E, Celis H, Fagard R, Keary L, Vandenhoven G, O'Brien ET, , . the Treatment of Hypertension Based on Home or Office Blood Pressure (THOP) Trial Investigators, the Treatment of Hypertension Based on Home or Office Blood Pressure (THOP) Trial Investigators Antihypertensive treatment based on blood pressure measurement at home or in the physician's office. A randomized controlled trial. JAMA 2004, 291:955-964. the Treatment of Hypertension Based on Home or Office Blood Pressure (THOP) Trial Investigators, the Treatment of Hypertension Based on Home or Office Blood Pressure (THOP) Trial Investigators.
21. Ibrahim MM, Rizk H, Appel LJ, El Aroussy W, Helmy S, Sharaf Y, Ashour Z, Kandil H, Rocella E, Whelton PK. Hypertension prevalence, awareness, treatment, and control in Egypt. Hypertension 1995, 26:886-890. 10.1161/01.HYP.26.6.886, 7490144.
22. Damasceno A, Azevedo A, Silva-Matos C, Prista A, Diogo D, Lunet N. Hypertension prevalence, awareness, treatment, and control in Mozambique: urban/rural gap during epidemiological transition. Hypertension 2009, 54:77-83. 10.1161/HYPERTENSIONAHA.109.132423, 19470872.
23. Costanzo S, Di Castelnuovo A, Zito F, Krogh V, Siani A, Arnout J, Cappuccio FP, Miller MA, van Dongen M, de Lorgeril M, de Gaetano G, Donati MB, Iacoviello L, , . European Collaborative Group of the IMMIDIET project, European Collaborative Group of the IMMIDIET project Prevalence, awareness, treatment and control of hypertension in healthy unrelated male-female pairs of European regions: the dietary habit profile in European communities with different risk of myocardioal infarction - the impact of migration as a model of gene-environment interaction. J Hypertens 2008, 26:2303-2311. 10.1097/HJH.0b013e328311ce04, 19008709, European Collaborative Group of the IMMIDIET project, European Collaborative Group of the IMMIDIET project.
24. Bertoia ML, Waring ME, Gupta PS, Roberts MB, Eaton CB. Implications of new hypertension guidelines in the United States. Hypertension 2011, 58:361-366. 10.1161/HYPERTENSIONAHA.111.175463, 21768528.
25. Staessen JA, Wang JG, Thijs L. Cardiovascular prevention and blood pressure reduction: a meta-analysis. Lancet 2001, 358:1305-1315. A published erratum appears in Lancet2002, 359:360, 10.1016/S0140-6736(01)06411-X, 11684211.
26. Turnbull F, , . Blood Pressure Lowering Treatment Trialists' Collaboration, Blood Pressure Lowering Treatment Trialists' Collaboration Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003, 362:1527-1535. Blood Pressure Lowering Treatment Trialists' Collaboration, Blood Pressure Lowering Treatment Trialists' Collaboration.
27. Staessen JA, Li Y, Thijs L, Wang JG. Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials. Hypertens Res 2005, 28:385-407. 10.1291/hypres.28.385, 16156503.
28. Verdecchia P, Reboldi G, Angeli A, Gattobigio R, Bentivoglio M, Thijs L, Staessen JA, Porcellati C. Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention. Hypertension 2005, 46:386-392. 10.1161/01.HYP.0000174591.42889.a2, 16009786.
29. Staessen JA, Thijs L, Fagard R, Celis H, Birkenhäger WH, Bulpitt CJ, de Leeuw PW, Fletcher AE, Forette F, Leonetti G, McCormack P, Nachev C, O'Brien E, Rodicio JL, Rosenfeld J, Sarti C, Tuomilehto J, Webster J, Yodfat Y, Zanchetti A, , . Systolic Hypertension in Europe (Syst-Eur) Trial Investigators, Systolic Hypertension in Europe (Syst-Eur) Trial Investigators Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. J Hypertens 2004, 22:847-857. 10.1097/00004872-200404000-00029, 15126928, Systolic Hypertension in Europe (Syst-Eur) Trial Investigators, Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
30. Cooper RS, Rotimi CN, Kaufman JS, Muna WFT, Mensah GA. Hypertension treatment and control in sub-Saharan Africa: the epidemiological basis for policy. Br Med J 1998, 316:614-617.
31. M'Buyamba-Kabangu JR, Biswika RT, Thijs L, Tshimanga GM, Ngalula FM, Disashi T, Kayembe PK, Richart T, M'buyamba-Kayamba JR, Lepira FB, Staessen JA. In-hospital mortality among black patients admitted for hypertension-related disorders in Mbuji Mayi, Congo. Am J Hypertens 2009, 22:643-648. 10.1038/ajh.2009.47, 19282818.
32. Arodiwe EB, Ike SO, Nwokediuko SC. Case fatality among hypertension-related admissions in Enugu, Nigeria. Niger J Clin Pract 2009, 12:153-156.
33. Seedat YK, Croasdale MA, Milne FJ, Opie LH, Pinkney-Atkinson VJ, Rayner BL, Veriava Y, , . Guideline Committee, Southern African Hypertension Society Directorate, Chronic Diseases, Disabilities and Geriatrics, National Department of Health, Guideline Committee, Southern African Hypertension Society Directorate, Chronic Diseases, Disabilities and Geriatrics, National Department of Health South African Hypertension Guideline 2006. S Afr Med J 2006, 96:337-362. Guideline Committee, Southern African Hypertension Society Directorate, Chronic Diseases, Disabilities and Geriatrics, National Department of Health, Guideline Committee, Southern African Hypertension Society Directorate, Chronic Diseases, Disabilities and Geriatrics, National Department of Health.
34. Lemogoum D, Seedat YK, Mabadeje AFB, Mendis S, Bovet P, Onwubere B, Blacket KN, Lenfant C, M'Buyamba-Kabangu JR, Block P, Belhocine M, Degaute JP, , . International Forum for Hypertension Control and Prevention in Africa, International Forum for Hypertension Control and Prevention in Africa Recommendations for prevention, diagnosis and management of hypertension and cardiovascular risk factors in sub-Saharan Africa. J Hypertens 2003, 21:1993-2000. 10.1097/00004872-200311000-00003, 14597837, International Forum for Hypertension Control and Prevention in Africa, International Forum for Hypertension Control and Prevention in Africa.
35. Guidelines Committee Guidelines for the management of hypertension in Nigeria 2005, Ezu Books Ltd, Enugu, Nigeria, Guidelines Committee.
36. Chobanian AV, Bakris GL, Black BK, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, , . Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206-1252. 10.1161/01.HYP.0000107251.49515.c2, 14656957, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee.
37. Douglas JG, Bakris GL, Epstein M, Ferdinand KC, Ferrario C, Flack JM, Jamerson KA, Jones WE, Haywood J, Maxey R, Ofili EO, Saunders E, Schiffrin EL, Sica DA, Sowers JR, Vidt DG, , . Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks, Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med 2003, 163:525-541. 10.1001/archinte.163.5.525, 12622600, Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks, Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks.
38. Flack JM, Sica DA, Bakris G, Brown AL, Ferdinand KC, Grimm RH, Hall WD, Jones WE, Kountz DS, Lea JP, Nasser S, Nesbitt SD, Saunders E, Scisney-Matlock M, Jamerson KA, , . International Society on Hypertension in Blacks, International Society on Hypertension in Blacks Management of hypertension in Blacks: an update of the International Society of Hypertension in Blacks Consensus Statement. Hypertension 2010, 56:780-800. 10.1161/HYPERTENSIONAHA.110.152892, 20921433, International Society on Hypertension in Blacks, International Society on Hypertension in Blacks.
39. Brown MJ, Cruickshank JM, Dominiczak AF, MacGregor GA, Poulter NR, Russell GI, Thom S, Williams B. Better blood pressure control: how to combine drugs?. J Hum Hypertens 2003, 17:81-86. 10.1038/sj.jhh.1001511, 12574784.
40. Brown MJ. Hypertension and ethnic group. Br Med J 2006, 332:833-836.
41. Khan JM, Beevers DG. Management of hypertension in ethnic minorities. Heart 2005, 91:1105-1109. 10.1136/hrt.2004.044560, 1769018, 16020613.
42. Zachariah PK, Messerli FH, Mroczek W. Low-dose bisoprolol/hydrochlorothiazide: an option in first-line antihypertensive treatment. Clin Ther 1993, 15:779-787.
43. Papademetriou V, Prisant M, Neutel JM, Weir MR. Efficacy of low-dose combination of bisoprolol/hydrochlorothiazide compared with amlodipine and enalapril in men and women with essential hypertension. Am J Cardiol 1998, 81:1363-1365. 10.1016/S0002-9149(98)00169-6, 9631978.
44. Prisant LM, Neutel JM, Ferdinand K, Papademetriou V, DeQuattro V, Hall WD, Weir MR. Low-dose combination therapy as first-line hypertension treatment for Blacks and Nonblacks. J Natl Med Assoc 1999, 91:40-48. 2568299, 10063787.
45. Devasenapathy N, Singh K, Prabhakaran D. Conduct of clinical trials in developing countries: a perspective. Curr Opin Cardiol 2009, 24:295-300. 10.1097/HCO.0b013e32832af21b, 19444095.